Baxter Pharmaceuticals India Private Limited
Indian Pharmaceutical Exporter ยท Gastrointestinal Specialist ยท $19.6M Total Trade ยท DGFT Verified
Baxter Pharmaceuticals India Private Limited is an Indian pharmaceutical exporter with a total trade value of $19.6M across 5 products in 4 therapeutic categories. Based on 465 verified export shipments from Indian Customs (DGFT) records, Baxter Pharmaceuticals India Private Limited is the #1 Indian exporter in 1 product including Furosemide. Top exports include Ondansetron ($10.8M), Furosemide ($7.1M), Metoclopramide ($947.6K).
Baxter Pharmaceuticals India Private Limited โ Export Portfolio & Destination Treemap

Who is Baxter Pharmaceuticals India Private Limited? โ Company Overview & Market Position
Baxter Pharmaceuticals India Private Limited (BPIPL) is a private unlisted company incorporated on June 8, 2005, under the Corporate Identification Number (CIN) U24230GJ2005PTC046211. The company is registered with the Ministry of Corporate Affairs (MCA) in India. BPIPL operates in the pharmaceutical manufacturing sector, focusing on the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's authorized capital is โน2,000 crore, with a paid-up capital of โน5.73 lakh.
BPIPL's registered office is located at Village: Vasana-Chacharwadi Tal: Sanand, Vasana Chacharwadi, Gujarat 382213, India. The company is a wholly owned subsidiary of Baxter International Inc., a global healthcare company. Baxter India has been serving its mission to save and sustain lives for over 25 years, with a robust presence across India, including manufacturing facilities in Ahmedabad and research and development centers in Bengaluru and Ahmedabad.